1340 related articles for article (PubMed ID: 12852480)
1. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.
Cook JC; Jacobson CF; Gao F; Tassinari MS; Hurtt ME; DeSesso JM
Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480
[TBL] [Abstract][Full Text] [Related]
2. Relationship between cyclooxygenase 1 and 2 selective inhibitors and fetal development when administered to rats and rabbits during the sensitive periods for heart development and midline closure.
Cappon GD; Cook JC; Hurtt ME
Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):47-56. PubMed ID: 12852483
[TBL] [Abstract][Full Text] [Related]
3. Comparison of developmental toxicology of aspirin (acetylsalicylic acid) in rats using selected dosing paradigms.
Gupta U; Cook JC; Tassinari MS; Hurtt ME
Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):27-37. PubMed ID: 12852481
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the developmental toxicity of aspirin in rabbits when administered throughout organogenesis or during sensitive windows of development.
Cappon GD; Gupta U; Cook JC; Tassinari MS; Hurtt ME
Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):38-46. PubMed ID: 12852482
[TBL] [Abstract][Full Text] [Related]
5. Comparison of developmental toxicity of selective and non-selective cyclooxygenase-2 inhibitors in CRL:(WI)WUBR Wistar rats--DFU and piroxicam study.
Burdan F
Toxicology; 2005 Jul; 211(1-2):12-25. PubMed ID: 15863244
[TBL] [Abstract][Full Text] [Related]
6. NSAIDs and developmental toxicity.
Tassinari MS; Cook JC; Hurtt ME
Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):3-4. PubMed ID: 12852479
[No Abstract] [Full Text] [Related]
7. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
8. Developmental toxicity evaluation of ibuprofen and tolmetin administered in triple daily doses to Wistar CRL:(WI)WUBR rats.
Burdan F
Birth Defects Res B Dev Reprod Toxicol; 2004 Oct; 71(5):321-30. PubMed ID: 15505808
[TBL] [Abstract][Full Text] [Related]
9. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs.
Gerstenfeld LC; Thiede M; Seibert K; Mielke C; Phippard D; Svagr B; Cullinane D; Einhorn TA
J Orthop Res; 2003 Jul; 21(4):670-5. PubMed ID: 12798067
[TBL] [Abstract][Full Text] [Related]
10. Maternal toxicity of nonsteroidal anti-inflammatory drugs as an important factor affecting prenatal development.
Burdan F; Szumilo J; Klepacz R
Reprod Toxicol; 2009 Sep; 28(2):239-44. PubMed ID: 19379806
[TBL] [Abstract][Full Text] [Related]
11. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
12. Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population.
García Rodríguez LA; Varas-Lorenzo C; Maguire A; González-Pérez A
Circulation; 2004 Jun; 109(24):3000-6. PubMed ID: 15197149
[TBL] [Abstract][Full Text] [Related]
13. [Developmental toxicity of naproxen].
Burdan F; Sykut J; Przybylski P
Pol Merkur Lekarski; 2007 Aug; 23(134):155-8. PubMed ID: 18044350
[TBL] [Abstract][Full Text] [Related]
14. Aspirin and NSAID sensitivity.
Stevenson DD
Immunol Allergy Clin North Am; 2004 Aug; 24(3):491-505, vii. PubMed ID: 15242723
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest.
Lees P; Landoni MF; Giraudel J; Toutain PL
J Vet Pharmacol Ther; 2004 Dec; 27(6):479-90. PubMed ID: 15601442
[TBL] [Abstract][Full Text] [Related]
16. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
[TBL] [Abstract][Full Text] [Related]
17. Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: A nested case-control study.
Ofori B; Oraichi D; Blais L; Rey E; Bérard A
Birth Defects Res B Dev Reprod Toxicol; 2006 Aug; 77(4):268-79. PubMed ID: 16929547
[TBL] [Abstract][Full Text] [Related]
18. The COX-2 inhibitor NS-398 causes T-cell developmental disruptions independent of COX-2 enzyme inhibition.
Xu H; Izon DJ; Loftin C; Spain LM
Cell Immunol; 2001 Dec; 214(2):184-93. PubMed ID: 12088417
[TBL] [Abstract][Full Text] [Related]
19. Different embryo-fetal toxicity effects for three VLA-4 antagonists.
Crofts F; Pino M; DeLise B; Guittin P; Barbellion S; Brunel P; Potdevin S; Bergmann B; Hofmann T; Lerman S; Clark RL
Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):55-68. PubMed ID: 15098199
[TBL] [Abstract][Full Text] [Related]
20. Postoperative non-steroidal anti-inflammatory drugs and colorectal anastomotic leakage. NSAIDs and anastomotic leakage.
Klein M
Dan Med J; 2012 Mar; 59(3):B4420. PubMed ID: 22381097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
